INNOVADERM CRO IS NOW INDERO.

Itch Insights: Hives & Highlights—Innovaderm’s 6th FREE Breakfast Event at the AAD

Indero

Indero

Team of Experts

Author picture

Innovaderm is celebrating its 25th anniversary in a big way with its 6th annual breakfast event at the AAD. Exciting surprises and an incredible program await you on March 8th.

Don’t miss this unique opportunity to connect and learn from world-renowned KOLs: Dr. Martin MetzDr. April Armstrong, and Dr. Jasmina Jankicevic.

  • Explore urticaria’s unmet needs
  • Discover pathophysiology updates on urticaria
  • Learn how dermatologists manage urticaria clinical trials

Register here for free!

Our distinguished panel can’t wait to share their knowledge with you.

See you in Orlando!

SHARE THIS POST

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

This field is for validation purposes and should be left unchanged.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte près de 30 ans d’expérience dans l’industrie pharmaceutique et CRO, s’étant distingué par son leadership exceptionnel, sa vision stratégique et son innovation. L’expertise de Jeff couvre des opérations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matière de création de valeur, de gestion des partenaires et d’opérations CRO ont toujours contribué au succès dans ses fonctions précédentes. Sous la direction de Jeff, Indero continue d’étendre ses capacités, faisant progresser les connaissances médicales et les nouvelles thérapies en dermatologie et en rhumatologie.

Revolutionize Your Topical Trials

Efficacy insights in days, not months.

 Indero’s Early Phase 1 model enables sponsors to initiate topical studies that detect early pharmacodynamic signals much sooner than traditional phase 1, using microdosing and transcriptomic analysis. This approach reduces preclinical requirements, shortens study duration from 8–12 weeks to ≤3 days, and lowers costs, helping teams make informed go/no-go decisions faster.